These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38436148)

  • 21. Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery.
    Ray AK; Sen Gupta PS; Panda SK; Biswal S; Bhattacharya U; Rana MK
    Comput Biol Med; 2022 Mar; 142():105183. PubMed ID: 34986429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting SARS-CoV-2 Main Protease (MPro) with Kinase Inhibitors: A Promising Approach for Discovering Antiviral and Anti-inflammatory Molecules against SARS-CoV-2.
    Anton DB; Galvez Bulhões Pedreira J; Zvirtes ML; Laufer SA; Ducati RG; Goettert M; Saraiva Macedo Timmers LF
    J Chem Inf Model; 2023 Jul; 63(13):4138-4146. PubMed ID: 37329322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a Biosafety Level 1 Cellular Assay for Identifying Small-Molecule Antivirals Targeting the Main Protease of SARS-CoV-2: Evaluation of Cellular Activity of GC376, Boceprevir, Carmofur, Ebselen, and Selenoneine.
    Fukumoto Y; Suzuki N; Hara R; Tanaka YK; Ogra Y
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the Development of SARS-CoV-2 Mpro Inhibitors.
    Agost-Beltrán L; de la Hoz-Rodríguez S; Bou-Iserte L; Rodríguez S; Fernández-de-la-Pradilla A; González FV
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress of SARS-CoV-2 Main protease peptide-like inhibitors.
    Liu X; Ren X; Hua M; Liu F; Ren X; Sui C; Li Q; Luo F; Jiang Z; Xia Z; Chen J; Yang B
    Chem Biol Drug Des; 2024 Jan; 103(1):e14425. PubMed ID: 38082476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isatin-based virtual high throughput screening, molecular docking, DFT, QM/MM, MD and MM-PBSA study of novel inhibitors of SARS-CoV-2 main protease.
    Varadharajan V; Arumugam GS; Shanmugam S
    J Biomol Struct Dyn; 2022 Oct; 40(17):7852-7867. PubMed ID: 33764269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation.
    Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ
    Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protocol for high-throughput screening of SARS-CoV-2 main protease inhibitors using a robust fluorescence polarization assay.
    Zhang J; Yan H; Yan G; Liu X; Wang Y; Chen Y
    STAR Protoc; 2022 Dec; 3(4):101794. PubMed ID: 36317181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel
    Sencanski M; Perovic V; Pajovic SB; Adzic M; Paessler S; Glisic S
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32842509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A robust high-throughput fluorescence polarization assay for rapid screening of SARS-CoV-2 papain-like protease inhibitors.
    Yan H; Liu Z; Yan G; Liu X; Liu X; Wang Y; Chen Y
    Virology; 2022 Sep; 574():18-24. PubMed ID: 35870326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Updated Review on SARS-CoV-2 Main Proteinase (M
    Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA
    Curr Top Med Chem; 2021; 21(6):442-460. PubMed ID: 33292134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral peptides inhibiting the main protease of SARS-CoV-2 investigated by computational screening and in vitro protease assay.
    Stewart J; Shawon J; Ali MA; Williams B; Shahinuzzaman ADA; Rupa SA; Al-Adhami T; Jia R; Bourque C; Faddis R; Stone K; Sufian MA; Islam R; McShan AC; Rahman KM; Halim MA
    J Pept Sci; 2024 Apr; 30(4):e3553. PubMed ID: 38031661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
    Goyal B; Goyal D
    ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detecting SARS-CoV-2 3CLpro expression and activity using a polyclonal antiserum and a luciferase-based biosensor.
    O'Brien A; Chen DY; Hackbart M; Close BJ; O'Brien TE; Saeed M; Baker SC
    Virology; 2021 Apr; 556():73-78. PubMed ID: 33548599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depicting the inhibitory potential of polyphenols from
    Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
    J Biomol Struct Dyn; 2022 Jun; 40(9):4110-4121. PubMed ID: 33292085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protocol to identify flavonoid antagonists of the SARS-CoV-2 main protease.
    Yang M; Lin L; Flaumenhaft R
    STAR Protoc; 2024 Jun; 5(2):102990. PubMed ID: 38583157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease.
    Mótyán JA; Mahdi M; Hoffka G; Tőzsér J
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based screening of novel lichen compounds against SARS Coronavirus main protease (Mpro) as potentials inhibitors of COVID-19.
    Joshi T; Sharma P; Joshi T; Pundir H; Mathpal S; Chandra S
    Mol Divers; 2021 Aug; 25(3):1665-1677. PubMed ID: 32602074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic Surveillance of SARS-CoV-2 M
    Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
    mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an
    Mahanta S; Chowdhury P; Gogoi N; Goswami N; Borah D; Kumar R; Chetia D; Borah P; Buragohain AK; Gogoi B
    J Biomol Struct Dyn; 2021 Jul; 39(10):3802-3811. PubMed ID: 32406317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.